ACTRN12618001121257	*NOT prior_therapy:Denosumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12619000769189	*NOT prior_therapy:platinum-based_antineoplastic_agent
ACTRN12619000844145	*NOT prior_therapy:Crizotinib; *NOT prior_therapy:Lorlatinib
ACTRN12620000861954	*NOT prior_therapy:BRAF_inhibitor
ACTRN12621000811808	*NOT prior_therapy:MET_inhibitor
NCT02323126	*NOT prior_therapy:Afatinib; *NOT prior_therapy:MET_inhibitor
NCT02477826	*NOT prior_therapy:systemic_therapy
NCT02504489	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Docetaxel
NCT02609776	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Lazertinib; *NOT prior_therapy:Poziotinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT02775435	*NOT prior_therapy:Cetuximab; *NOT prior_therapy:Crizotinib; *NOT prior_therapy:Erlotinib; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT02974725	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor
NCT03052608	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Crizotinib; *NOT prior_therapy:systemic_therapy
NCT03088540	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03088813	*NOT prior_therapy:Cisplatin; *NOT prior_therapy:systemic_therapy; *NOT prior_therapy:topoisomerase I inhibitor
NCT03175224	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor
NCT03215706	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:systemic_therapy
NCT03358875	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT03430063	*NOT prior_therapy:ALK_inhibitor
NCT03468426	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Sorafenib; *NOT prior_therapy:Sunitinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT03497767	*NOT prior_therapy:immune_checkpoint_blockade
NCT03515837	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03516981	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03539536	*NOT prior_therapy:immune_checkpoint_blockade
NCT03625323	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT03626545	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Taxane; *NOT prior_therapy:canakinumab
NCT03631199	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:canakinumab; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT03631784	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03735121	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT03829319	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03829332	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03840902	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT03948763	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT03974022	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Gefitinib; *NOT prior_therapy:Poziotinib
NCT03976323	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03976362	*NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03976375	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab
NCT03994393	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04035486	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04129502	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:systemic_therapy
NCT04139317	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:MET_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04154956	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Paclitaxel
NCT04194944	*NOT prior_therapy:Pembrolizumab
NCT04222972	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04248829	*NOT prior_therapy:systemic_therapy
NCT04256421	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04262856	*NOT prior_therapy:ALK_inhibitor
NCT04294810	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04432207	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT04434482	*NOT prior_therapy:PARP_inhibitor
NCT04447118	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04471428	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Cabozantinib; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04475939	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04487080	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:systemic_therapy
NCT04513925	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04524689	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04585815	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04619004	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Osimertinib; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:topoisomerase I inhibitor
NCT04623775	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04624204	*NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04644237	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04655976	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Docetaxel
NCT04656652	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Docetaxel
NCT04702880	*NOT prior_therapy:systemic_therapy
NCT04725188	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04746924	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04914897	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04921358	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
